A new approach using genetically modified T-cells — via CRISPR-Cas9 gene editing technology — safely and effectively targets cancer…
Articles by Marta Figueiredo, PhD
U.S. blood cancer specialists are aware of recent approvals for multiple myeloma patients and expect to increase their use…
The European Medicines Agency (EMA) has recommended that Darzalex (daratumumab) be approved in Europe, in combination with Revlimid (lenalidomide)…
Designing CAR T-cells to specifically target GPRC5D — a protein appreciably present on the surface of myeloma cells — may…
Kalytera’s cannabidiol (CBD) compound efficiently prevents graft-versus-host disease (GVHD) in patients receiving bone marrow transplants from matched unrelated…
Researchers have identified three genetic alterations associated with the known twofold to threefold risk of multiple myeloma among African-Americans. The…
Adding BioLineRx‘s BL-8040 to standard treatment greatly improves the mobilization of blood stem cells to be collected for…
Genetic analysis of multiple myeloma DNA from two different sources present in blood samples provides researchers equally relevant cancer information…
A multiple sclerosis (MS) treatment reduced a common painful side effect of Velcade (bortezomib) in a mouse model,…
The U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in combination with standard therapy for the treatment of patients…